Leading the Way in Life Science Technologies

GEN Exclusives

More »

May 1, Vol. 31, No. 9

  • Feature Articles

    • Protein Microarray Use Multiplies
    • Josh P. Roberts
    • Protein microarrays are many things to many people Like the more mature DNA “chips”, they are often patterns of tiny spots arrayed on a microscope-type slide, used to determine the makeup and amount of protein in a sample in a ... more »
    • GEN's 30th Anniversary: Fabs
    • With a number of monoclonal antibody products already on the market and many others in clinical trials, it’s clear that mAbs play an essential role in diagnosing and treating various diseases and medical disorders in the 21st century But smaller ... more »
    • Metabolomics Research Picks Up Speed
    • K. John Morrow Jr.
    • As an important discipline within systems biology, metabolomics is being explored by a number of laboratories for its potential in pharmaceutical development Studying metabolites can offer insights into the relationships between genotype and phenotype, as well as between genotype and ... more »
    • Scale-Up Woes Hinder Protein Purification
    • Angelo DePalma
    • Depending on the process and who provides the statistics, downstream processing accounts for between 50–80% of the cost of producing biotech drugs Whatever the exact number, protein purification looms large in the economic viability of a product Hence the interest ... more »
    • Cell Therapy Building on Momentum
    • Sue Pearson
    • Cell therapy for regenerative medicine is here, “but at the moment what we are offering is first-generation cell products,” said Nagy Habib, MD, CEO of LiverCyte and head of HPB surgery at London’s Hammersmith Hospital, at the recent “International Business ... more »